migraines

Novartis’ Aimovig tops topiramate in migraine face-off
Pharmaforum
Wed, 11/4/20 - 10:20 am
Novartis
Aimovig
Topiramate
migraines
clinical trials
Salvia’s migraine implant could be breakthrough, says FDA
Pharmaforum
Wed, 11/4/20 - 10:08 am
Salvia BioElectronics
FDA
devices
migraines
neurostimulation
Headache for Zosano as FDA turns down migraine patch
Pharmaforum
Wed, 10/21/20 - 11:52 pm
Zosano
FDA
migraines
migraine patch
Qtrypta
Amgen Highlights Long-Term Aimovig Data for Episodic Migraine
BioSpace
Mon, 10/5/20 - 11:43 am
Amgen
Novartis
Aimovig
migraines
episodic migraines
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Fierce Pharma
Fri, 09/11/20 - 12:11 pm
Eli Lilly
migraines
clinical trials
Reyvow
Biohaven
AbbVie
Satsuma Pharma's STS101 flunks late-stage migraine study, shares down 84%
Seeking Alpha
Thu, 09/10/20 - 10:23 am
migraines
Satsuma Pharmaceuticals
clinical trials
STS101
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Fierce Pharma
Mon, 08/10/20 - 10:52 pm
Teva Pharmaceutical
migraines
Ajovy
autoinjectors
Amgen
Eli Lilly
Biohaven hits social media jackpot with superceleb Khloe Kardashian as spokesperson for migraine med Nurtec ODT
Fierce Pharma
Thu, 07/16/20 - 11:22 pm
Biohaven
migraines
social media
celebrity endorsements
Nurtec ODT
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
Thu, 06/25/20 - 10:53 am
migraines
physicians
Biohaven
Eli Lilly
AbbVie
Nurtec ODT
Ubrelvy
Reyvow
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Fierce Pharma
Wed, 06/17/20 - 09:52 pm
Eli Lilly
migraines
Amgen
Teva Pharmaceutical
Lundbeck
Emgality
Will a Migraine Drug Save This Debt-Ridden Giant?
Motley Fool
Tue, 05/5/20 - 10:51 am
Teva Pharmaceutical
Ajovy
FDA
migraines
Axsome celebrates migraine PhIII win, shifting eyes toward a pair of Q4 submissions
Endpoints
Mon, 04/6/20 - 10:36 am
Axsome
clinical trials
migraines
AXS-05
Biohaven embraces digital to keep migraine launch on track despite COVID-19
Fierce Pharma
Wed, 03/25/20 - 11:54 pm
Biohaven
migraines
drug launches
digital pharma
COVID-19
pandemic
Nurtec
Reyvow, Migraine Drug That Treats Pain In Hours, Now Hits The Shelves
Forbes
Sat, 02/29/20 - 06:50 pm
Reyvow
migraines
drug launches
Eli Lilly
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Thu, 02/27/20 - 11:46 pm
Biohaven
FDA
migraines
Nurtec
Allergan
AbbVie
Ubrelvy
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
Tue, 02/25/20 - 10:40 am
ICER
migraines
Biohaven
Allergan
ubrogepant
rimegepant
Eli Lilly
Lasmiditan
The fourth CGRP migraine drug is here. Time for Lundbeck to prove it's worth $2B
Endpoints
Sat, 02/22/20 - 11:29 pm
Lundbeck
eptinezumab
migraines
CGRPs
Vyepti
Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst
Fierce Pharma
Fri, 02/21/20 - 10:49 am
Allergan
Botox
migraines
physicians
neurologists
CGRPs
Saniona Co-Founds New Migraine-Focused Company
BioSpace
Tue, 02/18/20 - 08:33 pm
Saniona
migraines
Denmark
Cephagenix
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Fierce Pharma
Fri, 01/31/20 - 12:14 pm
migraines
Eli Lilly
Reyvow
Allergan
Ubrelvy

Pages